Zurich Cantonal Bank’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,990
| Closed | -$193K | – | 2664 |
|
|
2019
Q3 | $193K | Hold |
1,990
| – | – | ﹤0.01% | 1258 |
|
|
2019
Q2 | $204K | Sell |
1,990
-723
| -27% | -$78K | ﹤0.01% | 1220 |
|
|
2019
Q1 | $309K | Sell |
2,713
-747
| -22% | -$54.9K | ﹤0.01% | 1005 |
|
|
2018
Q4 | $135K | Buy |
3,460
+485
| +16% | +$21K | ﹤0.01% | 1421 |
|
|
2018
Q3 | $162K | Hold |
2,975
| – | – | ﹤0.01% | 1433 |
|
|
2018
Q2 | $246K | Hold |
2,975
| – | – | ﹤0.01% | 1140 |
|
|
2018
Q1 | $198K | Sell |
2,975
-600
| -17% | -$34.6K | ﹤0.01% | 1207 |
|
|
2017
Q4 | $184K | Buy |
3,575
+384
| +12% | +$27.6K | ﹤0.01% | 1233 |
|
|
2017
Q3 | $285K | Buy |
3,191
+2,000
| +168% | +$152K | ﹤0.01% | 935 |
|
|
2017
Q2 | $71K | Buy |
1,191
+175
| +17% | +$9.78K | ﹤0.01% | 1562 |
|
|
2017
Q1 | $54K | Hold |
1,016
| – | – | ﹤0.01% | 1700 |
|
|
2016
Q4 | $51K | Buy |
1,016
+751
| +283% | +$40.2K | ﹤0.01% | 1689 |
|
|
2016
Q3 | $16K | Hold |
265
| – | – | ﹤0.01% | 2311 |
|
|
2016
Q2 | $14K | Hold |
265
| – | – | ﹤0.01% | 2269 |
|
|
2016
Q1 | $8K | Hold |
265
| – | – | ﹤0.01% | 2440 |
|
|
2015
Q4 | $12K | Hold |
265
| – | – | ﹤0.01% | 2320 |
|
|
2015
Q3 | $11K | Buy |
+265
| New | +$13.8K | ﹤0.01% | 1943 |
|
Zurich Cantonal Bank's ONCE Position: Q4 2019 in Review
Zurich Cantonal Bank sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 1,990 shares — an estimated $193K sold.
Zurich Cantonal Bank first reported a position in ONCE in Q3 2015 and held it in 17 quarters. The position peaked at $309K in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Zurich Cantonal Bank reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Zurich Cantonal Bank sold 1,990 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $193K.
- Zurich Cantonal Bank first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2015 and held it in 17 quarters.
- Zurich Cantonal Bank's Spark Therapeutics, Inc. Common Stock position peaked at $309K in Q1 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Zurich Cantonal Bank's 13F filing for Q4 2019, filed 21 Jan 2020.